Investors Relations
Business activities
The company's activities involve developing, distributing and selling nutritional products and pharmacy products, as well as associated services. The company is especially interested in business opportunities related to Vitamin K2 and its positive effects vis-à-vis improving bone and cardiovascular health. This includes investments in R&D and IPR (patents/documentation) associated with the use of Vitamin K2 as a commercial product.
Contact Us
For more information, please visit our profile on the Oslo Stock Exchange website or contact:
Erik Tjørstad
CFO
erik@nattopharma.com
Tel: (+47) 916 36 395